ReusS., PortillaJ., Sanchez-PayaJ.Low-level HIV viremia is associated with microbial translocation and inflammation. J Acquir Immune Defic Syndr2013; 62: 129–134.
2.
BastardJ.P., SoulieC., FellahiS.Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients. Antivir Ther2012; 17: 915–919.
3.
RuelleJ., DebaisieuxL., VancutsemE.HIV-1 low-level viraemia assessed with 3 commercial real-time PCR assays show high variability. BMC Infect Dis2012; 12: 100.
4.
Haïm-BoukobzaS., Morand-JoubertL., FlandreP.Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml. AIDS2011; 25: 341–344.
5.
KullerL.H., TracyR., BellosoW.Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med2008; 5: e203.
6.
SandlerN.G., WandH., RoqueA.Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis2011; 203: 780–790.
7.
KelesidisT., KendallM.A., YangO.O., HodisH.N., CurrierJ.S.Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection. J Infect Dis2012; 206: 1558–1567.
8.
ThiebautR., CharpentierC., DamondF.Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression. Clin Infect Dis2012; 55: 1417–1425.
